102 related articles for article (PubMed ID: 24506680)
1. Surfactant protein D in chornic obstructive pulmonary disease (COPD).
Moreno D; Garcia A; Lema D; De Sanctis JB
Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):42-7. PubMed ID: 24506680
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.
Bowler RP
COPD; 2012 Dec; 9(6):651-3. PubMed ID: 23244171
[TBL] [Abstract][Full Text] [Related]
3. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study.
Sin DD; Leung R; Gan WQ; Man SP
BMC Pulm Med; 2007 Oct; 7():13. PubMed ID: 17922919
[TBL] [Abstract][Full Text] [Related]
4. Correlation analysis of surfactant protein A and surfactant protein D with lung function in exhaled breath condensate from lung cancer patients with and without COPD.
Lin X; Wu Z; Fan Y; Chi M; Wang X; Zhang X; Sun D
Mol Med Rep; 2017 Oct; 16(4):4948-4954. PubMed ID: 28791362
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
7. Unifying thoracic biomarkers: surfactant protein-D and beyond.
Jaw JE; Sin DD
Expert Rev Respir Med; 2012 Apr; 6(2):147-54. PubMed ID: 22455487
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein D multimerization and gene polymorphism in COPD and asthma.
Fakih D; Akiki Z; Junker K; Medlej-Hashim M; Waked M; Salameh P; Holmskov U; Bouharoun-Tayoun H; Chamat S; Sorensen GL; Jounblat R
Respirology; 2018 Mar; 23(3):298-305. PubMed ID: 28960651
[TBL] [Abstract][Full Text] [Related]
9. Surfactant protein D: a lung specific biomarker in COPD?
Sin DD; Pahlavan PS; Man SF
Ther Adv Respir Dis; 2008 Apr; 2(2):65-74. PubMed ID: 19124360
[TBL] [Abstract][Full Text] [Related]
10. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.
Obeidat M; Li X; Burgess S; Zhou G; Fishbane N; Hansel NN; Bossé Y; Joubert P; Hao K; Nickle DC; van den Berge M; Timens W; Cho MH; Hobbs BD; de Jong K; Boezen M; Hung RJ; Rafaels N; Mathias R; Ruczinski I; Beaty TH; Barnes KC; Paré PD; Sin DD;
Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29191953
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Utility of Biomarkers in COPD.
Ambade VN; Sontakke AN; Barthwal MS; Tyagi R; Basannar DR
Respir Care; 2015 Dec; 60(12):1729-42. PubMed ID: 26106205
[TBL] [Abstract][Full Text] [Related]
12. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
[TBL] [Abstract][Full Text] [Related]
13. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
[TBL] [Abstract][Full Text] [Related]
14. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in COPD.
Agusti A; Sin DD
Clin Chest Med; 2014 Mar; 35(1):131-41. PubMed ID: 24507841
[TBL] [Abstract][Full Text] [Related]
16. SP-D polymorphisms and the risk of COPD.
Shakoori TA; Sin DD; Bokhari SN; Ghafoor F; Shakoori AR
Dis Markers; 2012; 33(2):91-100. PubMed ID: 22846212
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.
Duvoix A; Miranda E; Perez J; Sorensen GL; Holmskov U; Trapnell BC; Madsen J; Clark HW; Edwards LD; Miller BE; Tal-Singer RM; Lomas DA
COPD; 2011 Apr; 8(2):79-95. PubMed ID: 21495836
[TBL] [Abstract][Full Text] [Related]
18. Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D.
Tkacova R; McWilliams A; Lam S; Sin DD
Med Sci Monit; 2010 Nov; 16(11):CR540-4. PubMed ID: 20980958
[TBL] [Abstract][Full Text] [Related]
19. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
Kobayashi H; Kanoh S; Motoyoshi K
Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
[TBL] [Abstract][Full Text] [Related]
20. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.
Shakoori TA; Sin DD; Ghafoor F; Bashir S; Bokhari SN
Dis Markers; 2009; 27(6):287-94. PubMed ID: 20075511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
